Literature DB >> 18412267

Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia.

Marsel Mesulam1, Alissa Wicklund, Nancy Johnson, Emily Rogalski, Gabriel C Léger, Alfred Rademaker, Sandra Weintraub, Eileen H Bigio.   

Abstract

OBJECTIVE: To identify predictors of Alzheimer's disease (AD) versus frontotemporal lobar degeneration pathology in primary progressive aphasia (PPA), and determine whether the AD pathology is atypically distributed to fit the aphasic phenotype.
METHODS: Neuropsychological and neuropathological analyses of 23 consecutive PPA autopsies. All had qualitative determination of neurofibrillary tangle (NFT) density. Additional quantitation was done in four of the PPA/AD cases and four AD cases with the typical amnestic dementia of the Alzheimer type.
RESULTS: The sample contained mostly logopenic, agrammatic, and mixed forms of PPA. All six agrammatics had frontotemporal lobar degeneration (five of six with tauopathy). Seven of the 11 logopenics had AD. In logopenics, lower memory scores increased the probability of AD, but there were exceptions. The PPA/AD group showed predominance of entorhinal NFT typical of the amnestic dementia of the Alzheimer type. In the small subgroup examined quantitatively, neocortical NFTs were more numerous in the left hemisphere of PPA/AD. However, the asymmetry was low and inconsistent. Neuritic plaques did not display consistent asymmetry. Apolipoprotein E4, a major risk factor for typical AD, did not predict AD pathology in PPA.
INTERPRETATION: Subtyping PPA helps to predict AD versus frontotemporal lobar degeneration pathology at the group level. However, our results and the literature also indicate that no clinical predictor is completely reliable in individual patients. The inconsistent concordance of NFT distribution with the asymmetric atrophy and the nonamnestic phenotype also raises the possibility that the AD markers encountered at autopsy in PPA may not always reflect the nature of the initiating neurodegenerative process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18412267      PMCID: PMC2858311          DOI: 10.1002/ana.21388

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  49 in total

1.  An autopsy case of Alzheimer's disease presenting with primary progressive aphasia: a clinicopathological and immunohistochemical study.

Authors:  F Li; E Iseki; M Kato; Y Adachi; M Akagi; K Kosaka
Journal:  Neuropathology       Date:  2000-09       Impact factor: 1.906

2.  Three words three shapes: A clinical test of memory.

Authors:  S Weintraub; G M Peavy; M O'Connor; N A Johnson; D Acar; J Sweeney; I Janssen
Journal:  J Clin Exp Neuropsychol       Date:  2000-04       Impact factor: 2.475

3.  Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases.

Authors:  C J Galton; K Patterson; J H Xuereb; J R Hodges
Journal:  Brain       Date:  2000-03       Impact factor: 13.501

Review 4.  Primary progressive aphasia--a language-based dementia.

Authors:  M-Marsel Mesulam
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

5.  Primary progressive aphasia: PPA and the language network.

Authors:  Sreepadma P Sonty; M-Marsel Mesulam; Cynthia K Thompson; Nancy A Johnson; Sandra Weintraub; Todd B Parrish; Darren R Gitelman
Journal:  Ann Neurol       Date:  2003-01       Impact factor: 10.422

6.  MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

Authors:  C R Jack; M Slomkowski; S Gracon; T M Hoover; J P Felmlee; K Stewart; Y Xu; M Shiung; P C O'Brien; R Cha; D Knopman; R C Petersen
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

7.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease.

Authors:  G M McKhann; M S Albert; M Grossman; B Miller; D Dickson; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-11

8.  Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy.

Authors:  D F Tang-Wai; N R Graff-Radford; B F Boeve; D W Dickson; J E Parisi; R Crook; R J Caselli; D S Knopman; R C Petersen
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

9.  Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.

Authors:  Angela L Guillozet; Sandra Weintraub; Deborah C Mash; M Marsel Mesulam
Journal:  Arch Neurol       Date:  2003-05

10.  Cognition and anatomy in three variants of primary progressive aphasia.

Authors:  Maria Luisa Gorno-Tempini; Nina F Dronkers; Katherine P Rankin; Jennifer M Ogar; La Phengrasamy; Howard J Rosen; Julene K Johnson; Michael W Weiner; Bruce L Miller
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

View more
  204 in total

Review 1.  Changes in cognition.

Authors:  Marilyn S Albert
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

2.  Quantitative classification of primary progressive aphasia at early and mild impairment stages.

Authors:  M-Marsel Mesulam; Christina Wieneke; Cynthia Thompson; Emily Rogalski; Sandra Weintraub
Journal:  Brain       Date:  2012-04-23       Impact factor: 13.501

3.  Cortical neuroanatomic correlates of symptom severity in primary progressive aphasia.

Authors:  D Sapolsky; A Bakkour; A Negreira; P Nalipinski; S Weintraub; M-M Mesulam; D Caplan; B C Dickerson
Journal:  Neurology       Date:  2010-07-27       Impact factor: 9.910

Review 4.  Biomarkers to identify the pathological basis for frontotemporal lobar degeneration.

Authors:  Murray Grossman
Journal:  J Mol Neurosci       Date:  2011-07-22       Impact factor: 3.444

5.  The power of neuroimaging biomarkers for screening frontotemporal dementia.

Authors:  Corey T McMillan; Brian B Avants; Philip Cook; Lyle Ungar; John Q Trojanowski; Murray Grossman
Journal:  Hum Brain Mapp       Date:  2014-03-31       Impact factor: 5.038

Review 6.  Language impairment in primary progressive aphasia and other neurodegenerative diseases.

Authors:  D R Rahul; R Joseph Ponniah
Journal:  J Genet       Date:  2019-11       Impact factor: 1.166

Review 7.  Towards a clearer definition of logopenic progressive aphasia.

Authors:  Cristian E Leyton; John R Hodges
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

8.  Amyloid imaging in dementias with atypical presentation.

Authors:  David A Wolk; Julie C Price; Charles Madeira; Judy A Saxton; Beth E Snitz; Oscar L Lopez; Chester A Mathis; William E Klunk; Steven T DeKosky
Journal:  Alzheimers Dement       Date:  2012-01-30       Impact factor: 21.566

9.  Quantitative template for subtyping primary progressive aphasia.

Authors:  Marsel Mesulam; Christina Wieneke; Emily Rogalski; Derin Cobia; Cynthia Thompson; Sandra Weintraub
Journal:  Arch Neurol       Date:  2009-12

10.  Brain atrophy in primary progressive aphasia involves the cholinergic basal forebrain and Ayala's nucleus.

Authors:  Stefan J Teipel; Wilhelm Flatz; Nibal Ackl; Michel Grothe; Ingo Kilimann; Arun L W Bokde; Lea Grinberg; Edson Amaro; Vanja Kljajevic; Eduardo Alho; Christina Knels; Anne Ebert; Helmut Heinsen; Adrian Danek
Journal:  Psychiatry Res       Date:  2013-12-06       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.